105 related articles for article (PubMed ID: 15883222)
1. Letter regarding article by Jaeggi et al, "transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease".
Rosenthal E; Gordon PA; Simpson JM; Sharland GK
Circulation; 2005 May; 111(18):e287-8; author reply e287-8. PubMed ID: 15883222
[No Abstract] [Full Text] [Related]
2. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.
Jaeggi ET; Fouron JC; Silverman ED; Ryan G; Smallhorn J; Hornberger LK
Circulation; 2004 Sep; 110(12):1542-8. PubMed ID: 15353508
[TBL] [Abstract][Full Text] [Related]
3. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review.
Hutter D; Silverman ED; Jaeggi ET
Scand J Immunol; 2010 Sep; 72(3):235-41. PubMed ID: 20696021
[TBL] [Abstract][Full Text] [Related]
4. Letter by Jaeggi et al regarding article, "Perinatal outcome of fetal atrioventricular block: one-hundred sixteen cases from a single institution".
Jaeggi ET; Golding F; Silverman ED
Circulation; 2009 May; 119(20):e539; author reply e541-2. PubMed ID: 19470895
[No Abstract] [Full Text] [Related]
5. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.
Fesslova V; Vignati G; Brucato A; De Sanctis M; Butera G; Pisoni MP; Chiappa E; Acaia B; Meroni PL
Cardiol Young; 2009 Jun; 19(3):282-90. PubMed ID: 19383179
[TBL] [Abstract][Full Text] [Related]
6. Congenital complete heart block and maternal connective tissue disease.
Jayaprasad N; Johnson F; Venugopal K
Int J Cardiol; 2006 Sep; 112(2):153-8. PubMed ID: 16815568
[TBL] [Abstract][Full Text] [Related]
7. Use of terbutaline in the treatment of complete heart block in the fetus.
Robinson BV; Ettedgui JA; Sherman FS
Cardiol Young; 2001 Nov; 11(6):683-6. PubMed ID: 11813927
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of dexamethasone in the treatment of complete atrioventricular block of rheumatic origin].
Budianskiĭ MV; Isamukhamedov SZ
Ter Arkh; 1971 Feb; 43(2):56-8. PubMed ID: 5117909
[No Abstract] [Full Text] [Related]
9. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
Mevorach D; Elchalal U; Rein AJ
Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
[TBL] [Abstract][Full Text] [Related]
10. Letter by Marijon regarding article, "Perinatal outcome of fetal atrioventricular block: one-hundred sixteen cases from a single institution".
Marijon E
Circulation; 2009 May; 119(20):e540; author reply e541-2. PubMed ID: 19470896
[No Abstract] [Full Text] [Related]
11. Congenital heart block: current thoughts on management, morphologic spectrum, and role of intervention.
Martin TA
Cardiol Young; 2014 Oct; 24 Suppl 2():41-6. PubMed ID: 25247254
[No Abstract] [Full Text] [Related]
12. In-utero intervention for severe congenital heart disease.
Gardiner HM
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):49-61. PubMed ID: 17697798
[TBL] [Abstract][Full Text] [Related]
13. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
[TBL] [Abstract][Full Text] [Related]
14. Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome.
Breur JM; Kapusta L; Stoutenbeek P; Visser GH; van den Berg P; Meijboom EJ
J Matern Fetal Neonatal Med; 2008 Jul; 21(7):469-76. PubMed ID: 18570127
[TBL] [Abstract][Full Text] [Related]
15. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
[TBL] [Abstract][Full Text] [Related]
16. Fetal first-degree heart block, or where to set the confidence limit: comment on the article by Sonesson et al.
Rein AJ; Mevorach D; Perles Z; Shovali A; Elchalal U
Arthritis Rheum; 2005 Jan; 52(1):366; author reply 366-8. PubMed ID: 15641053
[No Abstract] [Full Text] [Related]
17. Neurological outcome in isolated congenital heart block and hydrops fetalis.
Breur JM; Gooskens RH; Kapusta L; Stoutenbeek P; Visser GH; van den Berg P; Meijboom EJ
Fetal Diagn Ther; 2007; 22(6):457-61. PubMed ID: 17652937
[TBL] [Abstract][Full Text] [Related]
18. Fetal dysrhythmias.
Api O; Carvalho JS
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):31-48. PubMed ID: 18243806
[TBL] [Abstract][Full Text] [Related]
19. Efficacy unproved of maternal dexamethasone for fetal heart block.
Carvalho JS; Shinebourne EA; Kyle P
Am J Obstet Gynecol; 1996 Aug; 175(2):502-3. PubMed ID: 8765278
[No Abstract] [Full Text] [Related]
20. Letter by Guettrot-Imbert et al regarding article, "early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies".
Guettrot-Imbert G; Costedoat-Chalumeau N; Amoura Z
Circulation; 2009 Nov; 120(21):e167; author reply e168. PubMed ID: 19933947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
